Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
BMC Complement Altern Med ; 19(1): 155, 2019 Jul 03.
Artículo en Inglés | MEDLINE | ID: mdl-31269947

RESUMEN

BACKGROUND: Osteochondral defects mostly occur as a result of trauma or articular degeneration. The poor regenerative ability of articular cartilage remains osteochondral defects are a tricky problem to deal with. The modern treatment strategies mainly focus on cartilage tissue engineering with bioactive materials. In this study, we aimed to develop icariin conditioned serum (ICS) together with hyaluronic acid (HA) and determine their ability in reparing osteochondral tissue in a critical-sized defect in rabbit knees. METHODS: Primary chondrocytes were incubated with serum conditioned with icariin at different concentrations, then cell proliferation rates and glycosaminoglycan (GAG) secretion were detected. Rabbits were treated with intra-articular injection of 0.5 mL normal saline (NS), ICS, HA and ICS + HA in the right knee joint, respectively. ICRS scores were used to assess the macroscopic cartilage regeneration. Histological and immunohistochemical analysis including H&E, Safranin O, toluidine blue and collagen II staining were used to determine the repair of cartilage and the regeneration of chondrocytes. RESULTS: Icariin at a low dose of 0.94 g/kg was identified to have significantly promoted the proliferation of chondrocytes and enhance the secretion of GAG. Femoral condyle from rabbits treated by ICS together with HA was observed to be integrated with native cartilage and more subchondral bone regeneration. ICS together with HA could promote repair of the cartilage defect and increase the neoformation of cartilage. CONCLUSIONS: These results demonstrated the potential of ICS combined with HA to promote reparative response in cartilage defects and the possible application in bioactive material based cartilage regeneration therapies.


Asunto(s)
Cartílago Articular/efectos de los fármacos , Condrogénesis/efectos de los fármacos , Flavonoides/uso terapéutico , Animales , Condrocitos/efectos de los fármacos , Epimedium , Flavonoides/farmacología , Ácido Hialurónico/uso terapéutico , Fitoterapia , Conejos , Suero , Viscosuplementos/uso terapéutico
2.
Drug Dev Ind Pharm ; 40(2): 157-62, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23339682

RESUMEN

BACKGROUND AND OBJECTIVE: To evaluate the effects of ischemia and reperfusion (IR) and ischemic preconditioning (IPC) on the metabolic activities of cytochrome P450 (CYP) isozymes in rats by a five-drug cocktail approach. METHODS: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, metoprolol and midazolam, respectively. Rats were randomly divided into IR, IPC and sham groups, and then injected the mixture of five probe drugs. Blood samples were collected at a series of time-points and the concentrations of probe drugs in plasma were determined by a HPLC method with UV detection. The pharmacokinetic parameters were calculated by the software of DAS 2.0. RESULTS: The parameters including t(1/2ß), CLs, AUC, MRT and K10 exhibited a similar tendency for both IR and IPC groups. Compared with sham group, CLs and K10 of five probe drugs were significantly lower (p < 0.05), AUC and t(1/2ß) of five or some probe drugs were significantly increased in IR and IPC groups (p < 0.05). Compared with IPC group, CLs of five probe drugs were decreased and AUC were significantly increased in the IR group (p < 0.05). CONCLUSION: IR can variably decrease the activities of CYP isozymes in rats and this decrease can be attenuated by IPC.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Precondicionamiento Isquémico/métodos , Daño por Reperfusión/enzimología , Animales , Cafeína/administración & dosificación , Cafeína/metabolismo , Clorzoxazona/administración & dosificación , Clorzoxazona/metabolismo , Combinación de Medicamentos , Interacciones Farmacológicas/fisiología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Femenino , Isoenzimas/metabolismo , Hígado/irrigación sanguínea , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Metoprolol/administración & dosificación , Metoprolol/metabolismo , Midazolam/administración & dosificación , Midazolam/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Daño por Reperfusión/tratamiento farmacológico , Tolbutamida/administración & dosificación , Tolbutamida/metabolismo
3.
J Surg Res ; 174(1): 176-83, 2012 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-21195427

RESUMEN

BACKGROUND: To study the protection offered by noninvasive delayed limb ischemic preconditioning (NDLIP) against cerebral ischemia reperfusion (I/R) injury in rats. MATERIALS AND METHODS: Healthy male Wistar rats were randomly divided into four groups. The delayed protection offered by NDLIP was estimated in light of changes in the neural behavior marker and cerebral tissue antioxidative ability. Neurological functions were studied by observing neural behavior. Total superoxide dismutase (T-SOD), manganese-superoxide dismutase (Mn-SOD), glutathione peroxidase (GSH-PX), and xanthine oxidase (XOD) activity in cerebral tissue and malonaldehyde (MDA) content were detected using a spectrophotometer. Mn-SOD mRNA was measured by the reverse transcription polymerase chain reaction method. RESULTS: Cerebral infarct size was diminished in the early cerebral ischemia preconditioning (ECIP)+I/R and NDLIP+I/R groups compared with the I/R group (P < 0.05). The cortical and hippocampal antioxidant enzyme activity and Mn-SOD expression were increased in the ECIP+I/R and NDLIP+I/R groups. In contrast, the cortical and hippocampal XOD activity and MDA content decreased in the ECIP+I/R and NDLIP+I/R groups. CONCLUSIONS: NDLIP decreased cerebral infarct size, increased cerebral antioxidative ability after I/R injury, and decreased peroxidative damage. The antioxidative protection offered by NDLIP was as effective as that offered by ECIP.


Asunto(s)
Antioxidantes/metabolismo , Isquemia Encefálica/metabolismo , Extremidades/irrigación sanguínea , Precondicionamiento Isquémico , Daño por Reperfusión/prevención & control , Animales , Glutatión Peroxidasa/metabolismo , Masculino , Malondialdehído/análisis , ARN Mensajero/análisis , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo
4.
Yao Xue Xue Bao ; 45(12): 1533-6, 2010 Dec.
Artículo en Zh | MEDLINE | ID: mdl-21351492

RESUMEN

The present study was to estimate pharmacokinetic parameters of metformin hydrochloride in 20 Chinese healthy volunteers with a limited sampling strategy (LSS), which will provide scientific data for bioequivalence and clinical application. A single dose of metformin was administrated to 20 healthy volunteers. The concentration of metformin in whole blood was determined by validated high performance liquid chromatography (HPLC) method. Multi-linear regression analysis was performed to establish a model to estimate AUC(0-24 h) and Cmax of metformin by LSS method. The LSS models were validated by the Jackknife method. The result indicated: the linearity relationship between AUC(0-24 h) or Cmax and single concentration point was poor. Several models for metformin AUC(0-24 h) or Cmax, estimation were better (r2 > 0.9, P < 0.05). Validation tests indicated that most informative sampling points (C2, C6 for AUC(0-24 h), C1.5, C2 for Cmax) provided accurate estimations of these parameters. So, a multi-linear regression model for estimation pharmacokinetic parameters of metformin by using LSS method is feasible.


Asunto(s)
Hipoglucemiantes/farmacocinética , Metformina/farmacocinética , Adulto , Área Bajo la Curva , Cromatografía Líquida de Alta Presión/métodos , Humanos , Hipoglucemiantes/administración & dosificación , Modelos Lineales , Masculino , Metformina/administración & dosificación , Tamaño de la Muestra , Equivalencia Terapéutica , Adulto Joven
5.
BMC Complement Med Ther ; 20(1): 193, 2020 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-32571325

RESUMEN

BACKGROUND: Osteochondral defects caused by an acute traumatic injury or articular degeneration remains difficult to be manipulated. Repair of articular defects is still a great challenge for both tissue engineers and orthopedic surgeons. Therefore, combination of biomaterials with cartilage promotive drugs is well worth being developed to support the regeneration of both cartilage and subchondral bone. METHODS: Rabbits undergoing osteochondral defect surgery were intrarticularly injected with icariin-conditioned serum (ICS), chitosan (CSSH) and combination of ICS with CSSH, respectively. Gait analysis was performed using VICON motion capture system. ICRS score and immunohistochemical (IHC) analysis including H&E, Safranin O, toluidine blue and collagen II staining was employed to evaluate macroscopic cartilage regeneration and determine the morphologic repair of cartilage. RESULTS: Rabbits with the treatment of ICS or CSSH alone showed mild improvement in hopping time and range of joint angles while ICS-CSSH group exhibited longer jumping time and larger range of joint angles. In addition, femoral condyle in ICS-CSSH rabbits could be seen with more native cartilage and subchondral bone regeneration in both macroscopic observation and IHC analysis. CONCLUSION: ICS combined with CSSH could promote the repair of osteochondral defect in rabbit knees. Combination of biomaterials with cartilage promotive drugs may ultimately have profound implications in the management of cartilage defect.


Asunto(s)
Cartílago Articular/efectos de los fármacos , Quitosano/farmacología , Medios de Cultivo Condicionados/farmacología , Flavonoides/farmacología , Traumatismos de la Rodilla/tratamiento farmacológico , Cicatrización de Heridas/efectos de los fármacos , Animales , Materiales Biocompatibles/farmacología , Cartílago Articular/lesiones , Línea Celular , China , Modelos Animales de Enfermedad , Quimioterapia Combinada , Masculino , Ratones , Conejos , Rango del Movimiento Articular , Suero , Ingeniería de Tejidos
6.
Lab Anim ; 43(3): 284-90, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19237454

RESUMEN

The present study was undertaken in order to evaluate feasibility of a limited sampling strategy (LSS) to predict the systemic clearance of midazolam (MDZ), which is a hepatic CYP3A activity phenotyping probe. Groups of rats pretreated with or without serial doses of ketoconazole, which is a selective inhibitor on CYP3A, were used as training set. Linear regression analysis and a Jack-knife validation procedure were performed based on plasma MDZ concentrations at specific time points after sublingual vein injection of MDZ to establish the most informative LSS equations for accurately estimating the clearance of MDZ. Another group of rats in the same setting was used as the validation set to confirm the individual values of estimated clearance (Clest) that were derived from the predictive equations developed in the training set. LSS that were derived from one, two or three sampling times, namely 90 min, 60-90 min, 30-60-90 min and 30-60-120 min, gave the best correlation and acceptable errors between the values of observed clearance (Clobs) and Clest and were chosen to evaluate hepatic CYP3A activity. Our results supported the hypothesis that using limited plasma sampling is simpler than the usual method of estimating CYP3A phenotyping by predicting the systemic clearance of MDZ when the hepatic activity of CYP3A is reduced in the rat. This experimental design offers opportunities to reduce animal use in the study of drug metabolism.


Asunto(s)
Adyuvantes Anestésicos/farmacocinética , Alternativas al Uso de Animales , Citocromo P-450 CYP3A/sangre , Hígado/enzimología , Midazolam/farmacocinética , Animales , Antifúngicos/farmacología , Interacciones Farmacológicas , Inhibidores Enzimáticos/farmacología , Inyecciones Intravenosas , Cetoconazol/farmacología , Hígado/efectos de los fármacos , Masculino , Midazolam/sangre , Valor Predictivo de las Pruebas , Ratas , Ratas Wistar , Organismos Libres de Patógenos Específicos
7.
Yao Xue Xue Bao ; 43(9): 905-11, 2008 Sep.
Artículo en Zh | MEDLINE | ID: mdl-19048780

RESUMEN

The present study was to evaluate feasibility of a limited sampling strategy (LSS) in the prediction of inhibited hepatic CYP3A activity with systemic clearance of midazolam (MDZ), a hepatic CYP3A activity phenotyping probe. Rats were pretreated with a serial doses of ketoconazole, a selective inhibitor on CYP3A. Blood samples were collected and detected for MDZ at specified time points after intravenous injection of MDZ. Stepwise regression analysis and a Jack-knife validation procedures were performed in one group of rats as training set to establish the most informative LSS model for accurately estimating the clearance of MDZ. Another group of rats with same treatment was used as validation set to estimate the individual clearance based on predictive equations derived from the training set. Bland-Altman plots showed a good agreement between the systemic clearance calculated from DAS (CLobs) and corresponding parameter that was derived from three LSS models (CLest). LSS models derived from two or three sampling time points, including 60, 90 min, 30, 60, 90 min and 30, 60, 120 min, exhibited a good accuracy and acceptable error for estimating the CLobs of MDZ to evaluate hepatic CYP3A activity, especially the 60, 90 min LSS model is most accurate and convenient. The results supported that limited plasma sampling to predict the systemic clearance of MDZ is easier than the usual method for estimating CYP3A phenotyping when the hepatic activity of CYP3A is reduced in the rat. The present study provided theoretical basis and laboratory evidence for LSS to clinically evaluate metabolizing function of liver and


Asunto(s)
Citocromo P-450 CYP3A/metabolismo , Cetoconazol/farmacología , Midazolam/farmacocinética , Animales , Área Bajo la Curva , Hidrocarburo de Aril Hidroxilasas/antagonistas & inhibidores , Hidrocarburo de Aril Hidroxilasas/genética , Hidrocarburo de Aril Hidroxilasas/metabolismo , Citocromo P-450 CYP3A/genética , Inhibidores del Citocromo P-450 CYP3A , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Inyecciones Intravenosas , Cetoconazol/administración & dosificación , Masculino , Tasa de Depuración Metabólica , Midazolam/sangre , Fenotipo , Distribución Aleatoria , Ratas , Ratas Wistar
10.
Free Radic Res ; 45(2): 201-10, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20942563

RESUMEN

This study was to explore whether repeated non-invasive limb ischemic pre-conditioning (NLIP) can confer an equivalent cardioprotection against myocardial ischemia-reperfusion (I/R) injury in acute diabetic rats to the extent of conventional myocardial ischemic pre-conditioning (MIP) and whether or not the delayed protection of NLIP is mediated by reducing myocardial oxidative stress after ischemia-reperfusion. Streptozotocin-induced diabetic rats were randomized to four groups: Sham group, the I/R group, the MIP group and the NLIP group. Compared with the I/R group, both the NLIP and MIP groups showed an amelioration of ventricular arrhythmia, reduced myocardial infarct size, increased activities of total superoxide dismutase (SOD), manganese-SOD and glutathione peroxidase, increased expression of manganese-SOD mRNA and decreased xanthine oxidase activity and malondialdehyde concentration (All p < 0.05 vs I/R group). It is concluded that non-invasive limb ischemic pre-conditioning reduces oxidative stress and attenuates myocardium ischemia-reperfusion injury in diabetic rats.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Precondicionamiento Isquémico/métodos , Infarto del Miocardio/metabolismo , Daño por Reperfusión Miocárdica/metabolismo , Animales , Arritmias Cardíacas/metabolismo , Arritmias Cardíacas/fisiopatología , Presión Sanguínea , Diabetes Mellitus Experimental/fisiopatología , Extremidades/irrigación sanguínea , Extremidades/fisiopatología , Expresión Génica , Glutatión Peroxidasa/metabolismo , Hemodinámica , Masculino , Malondialdehído/metabolismo , Modelos Animales , Infarto del Miocardio/fisiopatología , Daño por Reperfusión Miocárdica/fisiopatología , Daño por Reperfusión Miocárdica/prevención & control , Miocardio/metabolismo , Estrés Oxidativo , Ratas , Ratas Wistar , Estreptozocina/administración & dosificación , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Xantina Oxidasa/metabolismo
11.
Biol Pharm Bull ; 32(4): 717-20, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19336911

RESUMEN

A simplified, rapid, selective HPLC method for determining five cytochrome P450 (CYP) probe drugs in single run is described. The five specific probe substrates of caffeine, chlorzoxazone, tolbutamide, metoprolol and midazolam, together with the internal standard diazepam, were extracted using liquid-liquid extraction in rat plasma, followed by high-performance liquid chromatography (HPLC) using a C(18) column (5 microm particle size, 250x4.6 mm i.d.). The mobile phase consisted of a methanol and 50 mM phosphate buffer (pH 3.4, 65 : 35). All analytes were separated simultaneously in a single run that lasted less than 22 min. The detection limits range from 0.2-50 microg/ml for caffeine, 0.5-50 microg/ml for tolbutamide, metoprolol and midazolam, 0.2-100 microg/ml for chlorzoxazone, respectively. The intra- and inter-day precisions for five probe substrates were 1.38-11.10% and 3.39-11.33%, respectively, and the accuracy of five probe substrates ranged from 94.92-113.06% and 92.18-112.62%. The limit of quantification (LOQ) was 0.5 microg/ml for tolbutamide, midazolam and metoprolol, 0.2 microg/ml for caffeine and chlorzoxazone. The present method provides a robust, fast analytical tool for the five-probe drug cocktail. Finally, the method was suitable for determining the plasma concentration of these compounds and evaluating the CYP1A2, 2C9, 2D6, 2E1 and 3A4 activities in rats.


Asunto(s)
Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Preparaciones Farmacéuticas/química , Animales , Cromatografía Líquida de Alta Presión , Sistema Enzimático del Citocromo P-450/química , Inyecciones Intravenosas , Isoenzimas/química , Isoenzimas/efectos de los fármacos , Preparaciones Farmacéuticas/administración & dosificación , Control de Calidad , Ratas , Estándares de Referencia , Reproducibilidad de los Resultados , Soluciones , Espectrofotometría Ultravioleta
12.
Artículo en Zh | MEDLINE | ID: mdl-21158039

RESUMEN

AIM: To investigate the effects of ramipril on myocardial ischemia/reperfusion injury in diabetic rats, and to explore its mechanism according to the observation on myocardial ultrastructure. METHODS: Streptozotocin induced diabetic rats were divided randomly into three groups (n = 16): ischemia/reperfusion (I/R), ischemic preconditioning (IPC) and ramipril (RAM) group. Rats in RAM group were administered by RAM(1 mg x kg(-1) x d(-1)) orally for 4 weeks, the others were administered by normal saline. Then all rats were subjected to myocardial ischemia/ reperfusion injury. Rats in IPC group were preconditioned before ischemia. The ECG and the infarct size were examined. The changes of myocardial morphology were examined by light and electron microscopes. RESULTS: Compared with I/R group, the elevation of ST segment and the incidence of ventricular tachycardia and ventricular fibrillation during ischemia were significantly decreased, the infarct size at the end of reperfusion was remarkably reduced, the myocardial morphology were significantly improved, special structure of myofilaments and mitochondria remained clearly, blood vessels were unobstructed, injury of endothelium were decreased in PC and RAM groups. CONCLUSION: Ramipril administered for 4 weeks induces myocardial protection in diabetic rats, which is similar to that of IPC. The mechanism may be involved in protection of cardiocytes and mitochondria, and improvement of endothelial function.


Asunto(s)
Diabetes Mellitus Experimental/complicaciones , Precondicionamiento Isquémico Miocárdico/métodos , Daño por Reperfusión Miocárdica/prevención & control , Miocardio/ultraestructura , Ramipril/farmacología , Animales , Cardiotónicos/farmacología , Daño por Reperfusión Miocárdica/patología , Ratas
13.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 24(4): 448-51, 2008 Nov.
Artículo en Zh | MEDLINE | ID: mdl-21158149

RESUMEN

AIM: To explore the effects of noninvasive limb ischemic preconditioning on the anti-stress ability in mice. METHODS: Mice were divided into: normal group, control group, preconditioning group and drug group. Hypoxia tolerance test, swimming with weight loading, cold tolerance test and thermostable test were performed, and tolerance time in all the stringent state were observed. SOD activity of serum in hypoxia tolerance test and lactic acid of serum in swimming with weight loading test were determined. RESULTS: The time of hypoxia tolerance in preconditioning group was markedly increased, and SOD activity of preconditioning group mice was significantly higher than those of control group, while they were both shorter than drug group. The average time of swimming in preconditioning group was markedly increased and the level of increasing the swimming time of preconditioning was the same as caffeine. Preconditioning could increase the survival time on high temperature markedly, and there was no significantly difference in the level of increasing the survival time between preconditioning group and chlorpromazine group. Preconditioning could increase the time of cold tolerance markedly compared with normal group. CONCLUSION: Noninvasive limb ischemic preconditioning can improve the ability of anti-hypoxia, anti-fatigue, thermoresistance and cold-resistance in mice.


Asunto(s)
Adaptación Fisiológica/fisiología , Extremidades/irrigación sanguínea , Hipoxia/prevención & control , Precondicionamiento Isquémico/métodos , Estrés Fisiológico/fisiología , Animales , Fatiga/prevención & control , Femenino , Masculino , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA